title: Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?
authors.affiliation: Dept of Internal Medicine I, University of Cologne, Germany. Hinrich.Abken@Medizin.uni-koeln.DE
authors.forename: H
authors.initials: H
authors.lastname: Abken
authors.forename: A
authors.initials: A
authors.lastname: Hombach
authors.forename: U
authors.initials: U
authors.lastname: Reinhold
authors.forename: S
authors.initials: S
authors.lastname: Ferrone
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal